OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
97
Results
Show all
Save search
Copy query
Show results for
Unknown
(95)
Transcriptomics
(1)
Proteomics
(1)
Organisms
Homo sapiens
(1)
Alphavirus
(1)
Anemia
(1)
Betaherpesvirinae
(1)
Borrelia
(1)
Clostridium perfringens
(1)
Cowpox virus
(1)
Coxsackievirus
(1)
Cytomegalovirus
(1)
Dengue virus
(1)
EFO:0001352
(1)
Filoviridae
(1)
Hepatitis B virus
(1)
Human alphaherpesvirus 1
(1)
Human betaherpesvirus 5
(1)
Human immunodeficiency virus
(1)
Human immunodeficiency virus 1
(1)
Human immunodeficiency virus 2
(1)
Influenza A virus
(1)
Influenza C virus
(1)
Japanese encephalitis virus group
(1)
Lyssavirus rabies
(1)
Mus musculus
(1)
Oropouche virus
(1)
Orthopoxvirus vaccinia
(1)
Rattus
(1)
Staphylococcus aureus
(1)
Streptococcus pneumoniae
(1)
Viruses
(1)
West Nile virus
(1)
Repository
biostudies-arrayexpress
(1)
pride
(1)
Tissue
Brain
(1)
Cell culture
(1)
Microglial cell
(1)
Technology Type
Data-dependent acquisition
(1)
Mass Spectrometry
(1)
Publication Date
2015
(1)
2026
(1)
Study type
Transcription profiling by array
(1)
Release Date
2020
(17)
2022
(14)
2021
(14)
2025
(11)
2023
(8)
2024
(7)
2019
(6)
2018
(4)
2016
(4)
2015
(2)
2026
(2)
2017
(2)
2012
(2)
2011
(2)
2013
(1)
Lab affiliation
UNIL | University of Lausanne Faculty of Biology and Medicine Department of Biomedical Sciences Rue du Bugnon 7 CH-1005 Lausanne
(1)
Previous
page
1 / 10
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
10
Next
page
Sort
by:
Relevance
Page size
10
Genomic landscape of liquid biopsy mutations in TP53 and DNA damage genes in cancer patients.
Not available
S-EPMC10897416
|
biostudies-literature
Cite
Primary pulmonary arterial hypertension: Protocol to assess comprehensively in the rat the response to pharmacologic treatments.
Not available
S-EPMC6974770
|
biostudies-literature
Cite
Profile of entrectinib and its potential in the treatment of ROS1-positive NSCLC: evidence to date.
Not available
S-EPMC6747675
|
biostudies-literature
Cite
Lorlatinib in ALK- and ROS1-positive NSCLC: the future has a start.
Not available
S-EPMC5943229
|
biostudies-literature
Cite
Understanding and Overcoming Resistance to Selective FGFR Inhibitors across FGFR2-Driven Malignancies.
Not available
S-EPMC7616615
|
biostudies-literature
Cite
The efficacy of immune checkpoint inhibitors in thoracic malignancies.
Not available
S-EPMC9489136
|
biostudies-literature
Cite
Expert consensus on perioperative immunotherapy in non-small cell lung cancer: an editorial.
Not available
S-EPMC8743524
|
biostudies-literature
Cite
First-line immunotherapy in non-small cell lung cancer patients with poor performance status: a systematic review and meta-analysis.
Not available
S-EPMC8264315
|
biostudies-literature
Cite
Supplementation of Probiotics in Pregnant Women Targeting Group B Streptococcus Colonization: A Systematic Review and Meta-Analysis.
Not available
S-EPMC9657808
|
biostudies-literature
Cite
Adding PD-1/PD-L1 Inhibitors to Chemotherapy for the First-Line Treatment of Extensive Stage Small Cell Lung Cancer (SCLC): A Meta-Analysis of Randomized Trials.
Not available
S-EPMC7565587
|
biostudies-literature
Cite
Previous
page
1 / 10
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
10
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
